These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38349035)

  • 1. Approach to febrile neutropenia in patients undergoing treatments for hematologic malignancies.
    Stohs EJ; Abbas A; Freifeld A
    Transpl Infect Dis; 2024 Apr; 26(2):e14236. PubMed ID: 38349035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia.
    Rainess R; Campbell P; Santamala J; Kubin CJ; Mehta M
    J Pharm Pract; 2024 Apr; 37(2):301-306. PubMed ID: 36201023
    [No Abstract]   [Full Text] [Related]  

  • 3. Inpatient Antibiotic Stewardship Interventions in the Adult Oncology and Hematopoietic Stem Cell Transplant Population: A Review of the Literature.
    Pillinger KE; Bouchard J; Withers ST; Mediwala K; McGee EU; Gibson GM; Bland CM; Bookstaver PB
    Ann Pharmacother; 2020 Jun; 54(6):594-610. PubMed ID: 31771337
    [No Abstract]   [Full Text] [Related]  

  • 4. Febrile neutropenia in hematologic malignancies.
    Keng MK; Sekeres MA
    Curr Hematol Malig Rep; 2013 Dec; 8(4):370-8. PubMed ID: 23990311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De-escalation of empiric broad spectrum antibiotics in hematopoietic stem cell transplant recipients with febrile neutropenia.
    Rearigh L; Stohs E; Freifeld A; Zimmer A
    Ann Hematol; 2020 Aug; 99(8):1917-1924. PubMed ID: 32556455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial de-escalation in adult hematopoietic cell transplantation recipients with febrile neutropenia of unknown origin.
    Petteys MM; Kachur E; Pillinger KE; He J; Copelan EA; Shahid Z
    J Oncol Pharm Pract; 2020 Apr; 26(3):632-640. PubMed ID: 31423947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
    Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
    Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of time to antibiotics and clinical outcomes in adult hematologic malignancy patients with febrile neutropenia.
    Butts AR; Bachmeier CC; Dressler EV; Liu M; Cowden A; Talbert J; Adams VR
    J Oncol Pharm Pract; 2017 Jun; 23(4):278-283. PubMed ID: 28077045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardizing Febrile Neutropenia Management: Antimicrobial Stewardship in the Hematologic Malignancy Population.
    O'Horo JC; Marcelin JR; Abu Saleh OM; Barwise AK; Odean PM; Rivera CG; Tande AJ; Wilson JW; Osmon DR; Tosh PK
    J Oncol Pract; 2019 Sep; 15(9):e843-e848. PubMed ID: 31322989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of empiric antibiotic de-escalation in febrile neutropenia.
    Kroll AL; Corrigan PA; Patel S; Hawks KG
    J Oncol Pharm Pract; 2016 Oct; 22(5):696-701. PubMed ID: 26227319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninfectious causes of fever in hematologic malignancies. Are antibiotics still indicated?
    Shahid Z; Epstein DJ
    Curr Opin Infect Dis; 2023 Aug; 36(4):209-217. PubMed ID: 37431551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial.
    Ram R; Amit O; Adler A; Bar-On Y; Beyar-Katz O; Avivi I; Shasha D; Ben-Ami R
    Transplant Cell Ther; 2023 Nov; 29(11):708.e1-708.e8. PubMed ID: 37591446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tackling antibiotic resistance in febrile neutropenia: current challenges with and recommendations for managing infections with resistant Gram-negative organisms.
    Nouér SA; Nucci M; Anaissie E
    Expert Rev Hematol; 2015 Oct; 8(5):647-58. PubMed ID: 26115679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting bloodstream infections in febrile neutropenic patients with hematological malignancies, a decade-long single center retrospective observational study (2009-2019).
    El Omri H; Padmanabhan R; Taha RY; Kassem N; Elsabah H; Ellahie AY; Santimano AJJ; Al-Maslamani MA; Omrani AS; Elomri A; El Omri A
    J Infect Public Health; 2024 Jan; 17(1):152-162. PubMed ID: 38029491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and source of infection in cancer patients with febrile neutropenia: an experience from a developing country.
    Joudeh N; Sawafta E; Abu Taha A; Hamed Allah M; Amer R; Odeh RY; Salameh H; Sabateen A; Aiesh BM; Zyoud SH
    BMC Infect Dis; 2023 Feb; 23(1):106. PubMed ID: 36814229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended follow-up of an antibiotic cycling program for the management of febrile neutropenia in a hematologic malignancy and hematopoietic cell transplantation unit.
    Cumpston A; Craig M; Hamadani M; Abraham J; Hobbs GR; Sarwari AR
    Transpl Infect Dis; 2013 Apr; 15(2):142-9. PubMed ID: 23279656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the management of febrile neutropenia in hematologic patients.
    Escrihuela-Vidal F; Laporte J; Albasanz-Puig A; Gudiol C
    Rev Esp Quimioter; 2019 Sep; 32 Suppl 2(Suppl 2):55-58. PubMed ID: 31475812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Antibiotic De-escalation for Autologous Stem Cell Transplant Patients With Febrile Neutropenia in a Real-World Clinical Setting.
    Winget MD; Gatwood K; Jayani R; Biltibo E; Jallouk A; Jerkins J; Dholaria B; Kim TK; Savani B; Kassim A; McNeer E; Choi L; Orton L
    Transplant Cell Ther; 2024 Oct; 30(10):1031.e1-1031.e9. PubMed ID: 39074685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).
    Laporte-Amargos J; Gudiol C; Arnan M; Puerta-Alcalde P; Carmona-Torre F; Huguet M; Albasanz-Puig A; Parody R; Garcia-Vidal C; Del Pozo JL; Batlle M; Tebé C; Rigo-Bonnin R; Muñoz C; Padullés A; Tubau F; Videla S; Sureda A; Carratalà J
    Trials; 2020 May; 21(1):412. PubMed ID: 32423462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Work-up for Fever During Neutropenia for Both the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient.
    Satyanarayana G
    Infect Dis Clin North Am; 2019 Jun; 33(2):381-397. PubMed ID: 31005134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.